Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Launches Phase IV Tracking System; Baseline Is 20% Completion Rate

Related Content

Rx Industry Must Take Phase IV “Seriously,” Commissioner Tells PhRMA

Mar 31 2003

Pfizer Trovan Suspension Recommended In EU; Distribution Limited In U.S.

Jun 14 1999

ClinicalTrials.Gov: Confidentiality Concerns Are Decreasing, PhRMA Says

Aug 05 2002

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window